OBJECTIVE: To evaluate the national patterns of urologic follow up after @entity1566 ( @entity1566 ) and the occurrence and predictors of urological complications. MATERIALS AND METHODS: This retrospective cohort study used a 5% sample of Medicare data 2007-2010. The minimum adequate urologic surveillance was defined as a urologist visit, serum @entity1011 evaluation, and upper urinary tract imaging study within the 2-year period. @entity1 were classified to their most severe complication in a multivariate linear regression model. RESULTS: Among the 7162 @entity1 with @entity1566 , the majority were functionally paraplegic (82.4%) and Caucasian (80.9%). Among them, 4.9% received no screening studies over the 2-year period; 70.5% received some, but not all screening; and 24.6% received all three screening tests. @entity1 traveled a mean of 21.3    27.5 miles to receive care. A total of 35.7% of @entity1 saw a urologist during the 2-year period; 48.6% had some form of upper tract evaluation, with the majority being computed tomography scans; and 90.7% had serum @entity1011 evaluation. Of all @entity1 , 35.8% had a minor complication during their 2-year follow up, 17.1% had a moderate complication, and 8.0% had a severe complication. In our prediction model, @entity1 factors that correlated with increased complications included male gender, African American race, @entity451 , and receiving some or all of the @entity1494 recommended screening. @entity1 ' distance of travel to their treating physician (urologist or physiatrist) did not affect the rate of complications. CONCLUSION: Urological complications are common in @entity1 with @entity1566 who receive Medicare. Most of these @entity1 with @entity1566 are not receiving even the minimum recommended surveillance for these urological complications.

Urological Surveillance and Medical Complications after XXXX in the United States.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity1494 :: ('MESH:D001745', 'Disease') :: ['neurogenic bladder'] @entity1011 :: ('MESH:D003404', 'Chemical') :: ['creatinine'] @entity1566 :: ('MESH:D013119', 'Disease') :: ['spinal cord injury', 'SCI'] @entity451 :: ('MESH:C536857', 'Disease') :: ['paraplegia']
@entity1566 :: (MESH:D013119,Disease) :: ['Spinal Cord Injury']
